Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

The Cannigma

JANUARY 13, 2023

The ECS touches on nearly every biological function you have, including sleep, pain, appetite, body temperature, immune function, memory, and hormone regulation. 10 A 2001 review paper by cannabis researcher Dr. Ethan Russo details the historical use of cannabis for migraines.

Terpenes 135

Terpenes Strains THC Treatment 135

Cannabis Law Report

NOVEMBER 13, 2019

They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. The roadmap ahead includes clinical trials and more research in Denmark. Arundati Dandapani. Founder and CEO, . Generation1.ca. C) 613-890-7133. (T) T) @itadnura.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

NOVEMBER 24, 2021

Only one article appeared in the MJA in 2000 and again in 2001. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Full size image.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Drug Science. Matthew Johnson. Johns Hopkins University. in/ingmargorman/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51